Tower Research Capital LLC (Trc) Alaunos Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.04 - $0.13 $1,608 - $5,226	-40,203 Reduced 99.65%	143 $0
Q3 2023 Nov 14, 2023	BUY	$0.12 - $0.5 $2,641 - $11,006	22,013 Added 120.07%	40,346 $5,000
Q2 2023 Aug 14, 2023	BUY	$0.43 - $0.65 $11 - $16	26 Added 0.14%	18,333 $9,000
Q1 2023 May 09, 2023	BUY	$0.46 - $0.81 $113 - $199	246 Added 1.36%	18,307 $12,000
Q4 2022 Feb 10, 2023	SELL	$0.5 - $261.0 $11,723 - $6.12 Million	-23,446 Reduced 56.49%	18,061 $12,000
Q3 2022 Nov 10, 2022	BUY	$1.04 - $322.5 $35,224 - $10.9 Million	33,870 Added 443.5%	41,507 $71,000
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $3,888 - $11,760	-9,484 Reduced 55.39%	7,637 $10,000
Q1 2022 May 12, 2022	BUY	$0.62 - $1.17 $2,867 - $5,411	4,625 Added 37.01%	17,121 $11,000
Q4 2021 Feb 14, 2022	SELL	$1.09 - $1.89 $2,788 - $4,834	-2,558 Reduced 16.99%	12,496 $14,000
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $25,195 - $47,766	-17,497 Reduced 53.75%	15,054 $28,000
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $5,068 - $7,072	1,927 Added 6.29%	32,551 $86,000
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $30,258 - $60,087	10,730 Added 53.94%	30,624 $110,000
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $542,530 - $802,114	-259,584 Reduced 92.88%	19,894 $51,000
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $590,019 - $846,764	246,870 Added 757.08%	279,478 $704,000
Q2 2020 Aug 13, 2020	BUY	$2.2 - $3.71 $71,737 - $120,975	32,608 New	32,608 $107,000
Q4 2019 Feb 07, 2020	SELL	$3.95 - $5.35 $395 - $535	-100 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$4.13 - $6.94 $71,292 - $119,798	-17,262 Reduced 99.42%	100 $0
Q2 2019 Aug 13, 2019	BUY	$3.98 - $6.2 $68,762 - $107,117	17,277 Added 20325.88%	17,362 $101,000
Q1 2019 May 14, 2019	SELL	$2.0 - $4.4 $230 - $506	-115 Reduced 57.5%	85 $0
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $322 - $724	200 New	200 $0
Q2 2018 Aug 15, 2018	SELL	$3.02 - $4.94 $36,554 - $59,793	-12,104 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.46 - $5.14 $41,879 - $62,214	12,104 New	12,104 $47,000
Q4 2017 Feb 09, 2018	SELL	$4.0 - $6.54 $95,736 - $156,528	-23,934 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $119,430 - $157,246	23,934	23,934 $147,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $458M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account